Letter | Published:

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

Nature volume 378, pages 206208 (09 November 1995) | Download Citation

Subjects

Abstract

THE Mdm2 proto-oncogene was originally identified as one of several genes contained on a mouse double minute chromosome present in a transformed derivative of 3T3 cells1. Over expression of Mdm2 can immortalize primary cultures of rodent fibroblasts2. Human MDM2 is amplified in 30–40% of sarcomas, and is overex-pressed in leukaemic cells3,4. The Mdm2 oncoprotein forms a complex with the p53 tumour-suppressor protein and inhibits p53-mediated transregulation of gene expression5,6. Because Mdm2 expression increases in response to p53, Mdm2–p53 binding may autoregulate Mdm2 expression and modulate the activity of p53 in the cell7,8. We have created Mdm2-null and Mdm2/p53-null mice to determine whether Mdm2 possesses developmental functions in addition to the ability to complex with p53, and to investigate the biological role of Mdm2–p53 complex formation in development. Mice deficient for Mdm2 die early in development. In contrast, mice deficient for both Mdm2 and p53 develop normally and are viable. These results suggest that a critical role of Mdm2 in development is the regulation of p53 function.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , & Somatic Cell molec. Genet. 13, 235–244 (1987).

  2. 2.

    Molec. cell. Biol. 13, 301–306 (1993).

  3. 3.

    , , , & Nature 358, 80–83 (1992).

  4. 4.

    et al. Blood 82, 2617–2623 (1993).

  5. 5.

    , , , & Cell 69, 1237–1245 (1992).

  6. 6.

    , & Molec. Med. 1, 142–152 (1995).

  7. 7.

    , , , & Oncogene 8, 3411–3416 (1993).

  8. 8.

    , , & Genes Dev. 7, 1126–1132 (1993).

  9. 9.

    J. Embryol. exp. Morph. 42, 293–303 (1977).

  10. 10.

    , , & Development 113, 857–865 (1991).

  11. 11.

    et al. Nature 356, 215–221 (1992).

  12. 12.

    , & Molec. cell. Biol. 13, 4107–4114 (1993).

  13. 13.

    , , , & Science 253, 49–53 (1990).

  14. 14.

    et al. Molec. cell. Biol. 10, 5772–5781 (1990).

  15. 15.

    et al. Proc. natn. Acad. Sci. U.S.A. 87, 6166–6170 (1990).

  16. 16.

    , , , & Cancer Res. 51, 6304–6311 (1991).

  17. 17.

    , & Genes Dev. 5, 151–159 (1991).

  18. 18.

    et al. Oncogene 8, 2353–2360 (1993).

  19. 19.

    et al. Proc. natn. Acad. Sci. U.S.A. 91, 2684–2688 (1994).

  20. 20.

    , , , & Nature 360, 313–319 (1992).

  21. 21.

    , & Nature 336, 348–352 (1988).

  22. 22.

    , & in Guide to Techniques in Mouse development (eds Wassarman, P. M. & DePamphilis, M. L.) 855–878 (Academic, New York, 1993).

  23. 23.

    in The Atlas of Mouse Development 2–5 (Academic, San Diego, CA, 1992).

Download references

Author information

Affiliations

  1. Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA

    • Stephen N. Jones
    • , Amy E. Roe
    •  & Allan Bradley
  2. Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA

    • Amy E. Roe
    •  & Allan Bradley
  3. Department of Molecular Virology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA

    • Stephen N. Jones
    •  & Lawrence A. Donehower

Authors

  1. Search for Stephen N. Jones in:

  2. Search for Amy E. Roe in:

  3. Search for Lawrence A. Donehower in:

  4. Search for Allan Bradley in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/378206a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.